Cognizant Technology Solutions CTSH

Cognizant Technology Solutions is a multinational IT services provider that offers a range of consulting and business process outsourcing services. Originally founded in India, the company is headquartered in the US and serves enterprise customers spanning the financial services, healthcare, and resources industries. With most of its workforce located in India, Cognizant leverages a global delivery model that helps clients outsource their IT needs to offshore labor.

Con 17 acciones de CTSH (USD 990,34) habrías recibido USD 22,10 en dividendos en los últimos 12 meses.

CTSH hizo una división de acciones (split) de 2:1 el 17 de octubre de 2007: cada acción se convirtió en 2. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• Zacks Investment Research 29 sept

  CTSH or ROP: Which Is the Better Value Stock Right Now?

  A comparison of two IT services companies shows that Cognizant (CTSH) is the superior value option compared to Roper Technologies (ROP). Both stocks have a Zacks Rank #2 (Buy) with positive earnings outlooks, but CTSH offers better valuation metrics with a forward P/E of 9.89 versus ROP's 15.93, a PEG ratio of 1.06 versus 1.77, and a Value grade of A versus C.

  

• Zacks Investment Research 29 sept

  INOD vs. EXLS: Which AI & Data Services Stock Has More Upside?

  Innodata (INOD) and ExlService (EXLS) are both benefiting from rising AI adoption, but with different profiles. INOD shows faster growth with 56.1% first-half revenue surge and trades at a premium valuation (43.31X forward P/E), while EXLS offers greater scale, diversification, and profitability at a cheaper valuation (13.71X forward P/E). For growth-focused investors, INOD has more upside potential despite higher risks; EXLS presents a more balanced, defensive option.

  

• GlobeNewswire Inc. 24 sept

  Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the Region

  Europe's clinical data analytics market is projected to reach USD 105.6 billion by 2031, growing at a 27% CAGR through 2033. Growth is driven by healthcare digitalization, AI adoption, cloud deployment, and regulatory initiatives like the European Health Data Space. Software and cloud-based solutions lead the market, with healthcare providers and payers increasingly investing in analytics for improved patient outcomes and operational efficiency.

  

• Zacks Investment Research 21 sept

  Should First Trust Large Cap Core AlphaDEX ETF (FEX) Be on Your Investing Radar?

  First Trust Large Cap Core AlphaDEX ETF (FEX) is a passively managed large cap blend ETF with $1.55 billion in assets and a 0.57% expense ratio. The fund has returned 13.88% year-to-date and 16.07% over the past year, with a medium risk profile. It carries a Zacks ETF Rank of 3 (Hold), making it a sufficient option for large cap blend exposure, though competitors like Vanguard 500 Index Fund and iShares Core S&P 500 ETF offer lower expense ratios.

  

• Zacks Investment Research 16 sept

  Should You Invest in the First Trust Technology AlphaDEX ETF (FXL)?

  The article provides an in-depth analysis of the First Trust Technology AlphaDEX ETF (FXL), a passively managed technology sector ETF with $2.73 billion in assets. FXL has gained 25.61% year-to-date and 26.16% over the past year, with a 0.6% expense ratio. The fund holds 111 stocks with heavy allocation to Information Technology (85.3%), and is compared to alternatives like State Street's XLK and Vanguard's VGT, which offer lower expense ratios of 0.08% and 0.09% respectively.